Profile picture

Doctor Daniele Rodolico

University of Pisa, Pisa (Italy)
Membership: ESC Professional Member HFA Member
Follow
Biography
Daniele Rodolico is a resident physician at the University of Pisa, Italy. He received his MD cum laude from the Catholic University of Milan (UCSC). He was affiliated to research at the Division of Cardiology of the Department of Medicine, Karolinska Institutet, Stockholm. He was also a Visiting Student Trainee at the University of Texas Health Science Center at Houston and a Student Intern at the Cardiovascular Research Center of the Massachusetts General Hospital in Boston under a fellowship from the Giovanni Armenise Foundation at the Harvard Medical School. In 2021, he was a finalist of the Young investigator Award for Clinical Research of the HFA. In 2024, he was selected as Emerging Leader of the World Heart Federation. He is interested in heart failure, hypertension and cardiometabolic diseases.
Logo ESC

Contributor content

Mineralocorticoid receptor antagonists in heart failure with mildly reduced and preserved ejection fraction: an updated systematic review and meta-analysis of randomized clinical trials
Presentation
Mineralocorticoid receptor antagonists in heart failure with mildly reduced and preserved ejection fraction: an updated systematic review and meta-analysis of randomized clinical trials
Representation of frailty in contemporary trials of heart failure medications: a systematic review and dose-response meta-analysis
Presentation
Representation of frailty in contemporary trials of heart failure medications: a systematic review and dose-response meta-analysis
Eligibility for simultaneous initiation of the four pharmacological pillars of heart failure with reduced ejection fraction at discharge
Presentation
Eligibility for simultaneous initiation of the four pharmacological pillars of heart failure with reduced ejection fraction at discharge
Association between dose of medications and mortality in heart failure with reduced ejection fraction: a systematic review and dose-response meta-analysis
Presentation
Association between dose of medications and mortality in heart failure with reduced ejection fraction: a systematic review and dose-response meta-analysis
Target dose of heart failure medications is associated with better mortality/morbidity: data from the Swedish Heart Failure Registry
Presentation
Target dose of heart failure medications is associated with better mortality/morbidity: data from the Swedish Heart Failure Registry

ESC 365 is supported by